California-based diabetes data management company Glooko has generated $35m in a funding round led by Georgian Partners, and featuring participation from Mayo Clinic, European and existing investors Samsung and Medtronic. Glooko uses data analytics and artificial intelligence to turn patient data into practicable insights and develop personalised treatment plans. The funding will be used to expand sales and marketing teams, boost commercialisation efforts across Europe, Asia and the Middle East, and invest in R&D.
California-based diabetes data management company Glooko has generated $35m in a funding round led by Georgian Partners, and featuring participation from Mayo Clinic, Insulet and existing investors Samsung and Medtronic. Glooko uses data analytics and artificial intelligence to turn patient data into practicable insights and develop personalised treatment plans. The funding will be used to expand sales and marketing teams, boost commercialisation efforts across Europe, Asia and the Middle East, and invest in R&D.